D-backs void Brito's deal after PED suspension

D-backs void Brito's deal after PED suspension

DENVER -- Free-agent outfielder Socrates Brito, who had been signed to a contract by the D-backs this past spring, received a 50-game suspension for violating the Minor League Drug Prevention and Treatment Program.

Brito tested positive for metabolites of Stanozolol, a performance-enhancing substance.

Initially signed by the D-backs last month for $190,000, Brito had his contract voided by the club.

"We reached an agreement with Socrates prior to any testing," D-backs assistant GM Peter Woodfork said. "When we were notified of his entry testing results, we immediately voided that agreement. The Diamondbacks obviously agree with Major League Baseball's strict drug policy."

The ban will take effect immediately after Brito signs another contract, and it appears that will likely be with the D-backs.

"We will attempt to renegotiate new contract terms, but our first priority is to help the player understand the potential harm, policies and repercussions that surround such behavior," Woodfork said.